Downregulation of activation factors of endothelia and fibroblasts via lysophosphatidic acid signaling in a mouse lung cancer LL/2 cell line

Journal of Receptors and Signal Transduction

Volumn 33, Issue 5, 2013, Pages 286-290

  Tanabe, Eriko ^a   Kitayoshi, Misaho ^a   Hirane, Miku ^a   Araki, Mutsumi ^a   Dong, Yan ^a   Fukushima, Nobuyuki ^a   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Cell migration; Fibroblast; LPA3; Lung cancer

Indexed keywords

FIBROBLAST GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ACTIVATION; CONTROLLED STUDY; FIBROBLAST; LUNG CANCER; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYSOPHOSPHOLIPIDS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885008570     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2013.823998     Document Type: Article

References (24)

1. Lin M-E, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 2010;91:130-8.
2. Contos JJA, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol 2000;58:1188-96.
3. Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 2004;73:321-54. (Pubitemid 39050372)
4. An S, Bleu T, Halmark OG, Goetzl EJ. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem 1998;273:7906-10. (Pubitemid 28168837)
5. Tsujino M, Fujii M, Okabe K, et al. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch 2010;457:669-76.
6. Okabe K, Hayashi M, Wakabayashi N, et al. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells. Pathobiology 2010;77:278-82.
7. Tanabe E, Shibata A, Inoue S, et al. Regulation of cell motile activity through the different induction of LPA receptors by estrogens in liver epithelial WB-F344 cells. Biochem Biophys Res Commun 2012;428:105-9.
8. Yu S, Murph MM, Lu Y, et al. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst 2008;100:1630-42.
9. Hayashi M, Okabe K, Kato K, et al. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett 2012;316:91-6.
10. Okabe K, Hayashi M, Yamawaki Y, et al. Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells. Mol Carcinog 2011;50:635-42.
11. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.
12. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76. (Pubitemid 36749215)
13. Räsänen K, Vaheri A. Activation of fibroblasts in cancer stroma. Exp Cell Res 2010;316:2713-22.
14. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6:392-401.
15. Kitayoshi M, Kato K, Tanabe E, et al. Enhancement of endothelial cell migration by constitutively active LPA1-expressing tumor cells. Biochem Biophys Res Commun 2012;422:339-43.
16. Kitayoshi M, Fukui R, Tanabe E, et al. Different effects on cell proliferation and migration abilities of endothelial cells by LPA1 and LPA3 in mammary tumor FM3A cells. J Recept Sig Transd 2012;32:209-13.
17. Hayashi M, Okabe K, Yamawaki Y, et al. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem Biophys Res Commun 2011;405:450-4.
18. Shano S, Hatanaka K, Ninose S, et al. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta 2008;1783: 748-59.
19. Okabe K, Hayashi M, Kato K, et al. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol Carcinog 2013;52:247-54. DOI: 10.1002/mc.21851.
20. Takahashi J, Saito T, Taniguchi M, et al. A novel Gaq/11-selective inhibitor. J Biol Chem 2004;279:47438-45.
21. Fischer DJ, Nusser N, Virag T, et al. Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors. Mol Pharmacol 2001;60:776-84. (Pubitemid 32900260)
22. Fujita T, Miyamoto S, Onoyama I, et al. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett 2003;192:161-9. (Pubitemid 36369270)
23. Hu Y-L, Tee M-K, Goetzl EJ, et al. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian carcinoma cells. J Natl Cancer Inst 2001;93: 762-8. (Pubitemid 32514799)
24. Shida D, Kitayama J, Yanaguchi H, et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 2003;63:1706-11. (Pubitemid 36373664)